drugset / Trial / NCT00461370
Safety Study of SRX251 Capsules in Healthy Female Volunteers
Non-randomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety of SRX251 when given orally. The amount of SRX251 in the blood will also be measured. Healthy women, ages 18-50 years who have been surgically sterilized by tubal ligation, will be enrolled in this study.
Timeline
- Start
- 2007-04
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SRX251 | Unknown | — | Oral |
Indications
No indication recorded.